These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 39201322)

  • 1. The Impact of Serum/Plasma Proteomics on SARS-CoV-2 Diagnosis and Prognosis.
    D'Amato M; Grignano MA; Iadarola P; Rampino T; Gregorini M; Viglio S
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic Approaches to Study SARS-CoV-2 Biology and COVID-19 Pathology.
    Haas P; Muralidharan M; Krogan NJ; Kaake RM; Hüttenhain R
    J Proteome Res; 2021 Feb; 20(2):1133-1152. PubMed ID: 33464917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open Science Resources for the Mass Spectrometry-Based Analysis of SARS-CoV-2.
    Bittremieux W; Adams C; Laukens K; Dorrestein PC; Bandeira N
    J Proteome Res; 2021 Mar; 20(3):1464-1475. PubMed ID: 33605735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass spectrometry-based proteomic platforms for better understanding of SARS-CoV-2 induced pathogenesis and potential diagnostic approaches.
    Ahsan N; Rao RSP; Wilson RS; Punyamurtula U; Salvato F; Petersen M; Ahmed MK; Abid MR; Verburgt JC; Kihara D; Yang Z; Fornelli L; Foster SB; Ramratnam B
    Proteomics; 2021 May; 21(10):e2000279. PubMed ID: 33860983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics-Based Insights Into the SARS-CoV-2-Mediated COVID-19 Pandemic: A Review of the First Year of Research.
    Praissman JL; Wells L
    Mol Cell Proteomics; 2021; 20():100103. PubMed ID: 34089862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics in the COVID-19 Battlefield: First Semester Check-Up.
    Grenga L; Armengaud J
    Proteomics; 2021 Jan; 21(1):e2000198. PubMed ID: 33236484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood proteomics of COVID-19 infection: An update.
    Alexovič M; Bondarchuk T; Uličná C; Sabo J
    Clin Chim Acta; 2024 Aug; 562():119881. PubMed ID: 39033952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valuable Contributions and Lessons Learned from Proteomics and Metabolomics Studies of COVID-19.
    Chatterjee B; Thakur SS
    J Proteome Res; 2024 Oct; 23(10):4171-4187. PubMed ID: 39157976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoaffinity Capillary Electrophoresis in the Era of Proteoforms, Liquid Biopsy and Preventive Medicine: A Potential Impact in the Diagnosis and Monitoring of Disease Progression.
    Guzman NA; Guzman DE
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping the SARS-CoV-2-Host Protein-Protein Interactome by Affinity Purification Mass Spectrometry and Proximity-Dependent Biotin Labeling: A Rational and Straightforward Route to Discover Host-Directed Anti-SARS-CoV-2 Therapeutics.
    Terracciano R; Preianò M; Fregola A; Pelaia C; Montalcini T; Savino R
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery.
    Li Y; Hou G; Zhou H; Wang Y; Tun HM; Zhu A; Zhao J; Xiao F; Lin S; Liu D; Zhou D; Mai L; Zhang L; Zhang Z; Kuang L; Guan J; Chen Q; Wen L; Zhang Y; Zhuo J; Li F; Zhuang Z; Chen Z; Luo L; Liu D; Chen C; Gan M; Zhong N; Zhao J; Ren Y; Xu Y
    Signal Transduct Target Ther; 2021 Apr; 6(1):155. PubMed ID: 33859163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.
    Stukalov A; Girault V; Grass V; Karayel O; Bergant V; Urban C; Haas DA; Huang Y; Oubraham L; Wang A; Hamad MS; Piras A; Hansen FM; Tanzer MC; Paron I; Zinzula L; Engleitner T; Reinecke M; Lavacca TM; Ehmann R; Wölfel R; Jores J; Kuster B; Protzer U; Rad R; Ziebuhr J; Thiel V; Scaturro P; Mann M; Pichlmair A
    Nature; 2021 Jun; 594(7862):246-252. PubMed ID: 33845483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization by Quantitative Serum Proteomics of Immune-Related Prognostic Biomarkers for COVID-19 Symptomatology.
    Villar M; Urra JM; Rodríguez-Del-Río FJ; Artigas-Jerónimo S; Jiménez-Collados N; Ferreras-Colino E; Contreras M; de Mera IGF; Estrada-Peña A; Gortázar C; de la Fuente J
    Front Immunol; 2021; 12():730710. PubMed ID: 34566994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid and sensitive detection of SARS-CoV-2 infection using quantitative peptide enrichment LC-MS analysis.
    Hober A; Tran-Minh KH; Foley D; McDonald T; Vissers JP; Pattison R; Ferries S; Hermansson S; Betner I; Uhlén M; Razavi M; Yip R; Pope ME; Pearson TW; Andersson LN; Bartlett A; Calton L; Alm JJ; Engstrand L; Edfors F
    Elife; 2021 Nov; 10():. PubMed ID: 34747696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma proteomics identify potential severity biomarkers from COVID-19 associated network.
    Sahin AT; Yurtseven A; Dadmand S; Ozcan G; Akarlar BA; Kucuk NEO; Senturk A; Ergonul O; Can F; Tuncbag N; Ozlu N
    Proteomics Clin Appl; 2023 Mar; 17(2):e2200070. PubMed ID: 36217943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol to identify biomarkers in patients with post-COVID condition using multi-omics and machine learning analysis of human plasma.
    Khoramjoo M; Srinivasan K; Wang K; Wishart D; Prasad V; Oudit GY
    STAR Protoc; 2024 Jun; 5(2):103041. PubMed ID: 38678567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-omics landscapes reveal heterogeneity in long COVID patients characterized with enhanced neutrophil activity.
    Lin K; Cai J; Guo J; Zhang H; Sun G; Wang X; Zhu K; Xue Q; Zhu F; Wang P; Yuan G; Sun Y; Wang S; Ai J; Zhang W
    J Transl Med; 2024 Aug; 22(1):753. PubMed ID: 39135185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometry-based proteomics analyses of post-translational modifications and proteoforms in human pituitary adenomas.
    Li J; Zhan X
    Biochim Biophys Acta Proteins Proteom; 2021 Mar; 1869(3):140584. PubMed ID: 33321259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19.
    Lazari LC; Ghilardi FR; Rosa-Fernandes L; Assis DM; Nicolau JC; Santiago VF; Dalçóquio TF; Angeli CB; Bertolin AJ; Marinho CR; Wrenger C; Durigon EL; Siciliano RF; Palmisano G
    Life Sci Alliance; 2021 Aug; 4(8):. PubMed ID: 34168074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Multiomics Data to Understand Host-Pathogen Interactions in COVID-19 Pathogenesis.
    Aggarwal S; Acharjee A; Mukherjee A; Baker MS; Srivastava S
    J Proteome Res; 2021 Feb; 20(2):1107-1132. PubMed ID: 33426872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.